Trial Profile
Immunotherapy vs immuno-chemotherapy in patients with metastatic kidney carcinoma.
Status:
Recruiting
Phase of Trial:
Phase III
Latest Information Update: 21 Jun 2011
Price :
$35
*
At a glance
- Drugs Aldesleukin (Primary) ; Gemcitabine (Primary) ; Vinorelbine (Primary)
- Indications Renal cancer
- Focus Therapeutic Use
- 21 Jun 2011 New trial record